Key facts
- T. Rowe Price Investment Management, Inc. filed SCHEDULE 13G/A for APPLIED THERAPEUTICS INC COMMON STOCK (APLT).
- Disclosed ownership: 11%.
- Date of event: 30 Apr 2025.
T. Rowe Price Investment Management, Inc. - 30 Apr 2025 SCHEDULE 13G/A Report for APPLIED THERAPEUTICS INC COMMON STOCK (APLT)
- Filing Manager
- T. Rowe Price Investment Management, Inc.
- Reporting Manager
- T. Rowe Price Investment Management, Inc.
- Symbol
- APLT
- Shares outstanding
- 141,932,600 shares
- Disclosed Ownership
- 15,612,586 shares
- Ownership
- 11%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 May 2025, 10:37:54 UTC
- Date of event
- 30 Apr 2025
- Previous filing
- 07 May 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Key filing fact
T. Rowe Price Investment Management, Inc. disclosed 11% ownership in APPLIED THERAPEUTICS INC COMMON STOCK (APLT) on 30 Apr 2025.
Change
- Previous schedule filing date: 07 May 2025.
- Current filing was accepted on 07 May 2025, 10:37.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 11% | 15,612,586 | 15,612,586 | 0 | Ellen York | Vice President |
CIK / CUSIP context first